Skip to main content
main-content

Diabetes complications and comorbidities

Gastrointestinal disorders

12-05-2018 | Non-alcoholic fatty liver disease | Article

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Lonardo A, Lugari S, Ballestri S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1266-0

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

06-01-2018 | Gastrointestinal disorders | Highlight | News

High burden of GI symptoms in patients with type 1 diabetes

People with type 1 diabetes are approximately twice as likely to experience gastrointestinal symptoms as those without, and these symptoms are associated with poor glycemic control and quality of life, study results suggest.

05-18-2018 | Nutritional management | Article

Adherence to special diets and its association with meeting the nutrient recommendations in individuals with type 1 diabetes

Ahola AJ, Forsblom C, Groop PH. Acta Diabetol 2018. doi: 10.1007/s00592-018-1159-2

04-18-2018 | Artificial pancreas systems | Article

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis

Bekiari E et al. BMJ 2018; 361: k1310. doi: 10.1136/bmj.k1310 

03-20-2018 | Diet | News

DiRECT: Effects on insulin and liver fat revealed

Researchers from the DiRECT trial have reported large positive effects on liver fat and insulin secretion among people who achieved type 2 diabetes remission in response to a very-low-calorie diet.

02-07-2018 | Risk factors | Highlight | News

‘Subtle’ metabolic derangement seen decades before diabetes diagnosis

Research shows that changes in markers of the metabolic syndrome and fatty liver disease are present more than 20 years before people receive a diagnosis of type 2 diabetes.

12-29-2017 | Nephropathy | Review | Article

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

Nat Rev Endocrinol 2017; 14: 99–114. doi: 10.1038/nrendo.2017.173

10-27-2017 | Risk factors | Review | Article

Diabetes and the pancreatobiliary diseases

Shafqet M, Sharzehi K. Curr Treat Options Gastro 2017; 15: 508–519. doi: 10.1007/s11938-017-0163-x

10-06-2017 | Gastrointestinal disorders | Article

Screening for celiac disease in poorly controlled type 2 diabetes mellitus: Worth it or not?

Kizilgul M et al. BMC Endocr Disord 2017; 17: 62. doi: 10.1186/s12902-017-0212-4

09-20-2017 | Non-alcoholic fatty liver disease | EASD 2017 | News

NAFLD: The associated risks and potential treatments

Researchers presented the results of several studies investigating the risks associated with nonalcoholic fatty liver disease and potential treatment strategies at the EASD annual meeting in Lisbon, Portugal.

09-13-2017 | Diet | EASD 2017 | News

Hypocaloric low-fat and low-carbohydrate diets beneficial in type 2 diabetes

Results of a randomized trial suggest that patients with type 2 diabetes experience metabolic benefits from a hypocaloric diet regardless of whether it is low in fat or low in carbohydrate content.

08-03-2017 | Ipragliflozin | News

Ipragliflozin and pioglitazone ‘equally beneficial’ for type 2 diabetes with NAFLD

Results of a randomized trial suggest that the sodium-glucose cotransporter 2 inhibitor ipragliflozin has equivalent efficacy to pioglitazone for the treatment of patients with type 2 diabetes complicated by nonalcoholic fatty liver disease.

07-18-2017 | Gastrointestinal disorders | Review | Article

Gastroparesis: Medical and therapeutic advances

Navas CM, Patel NK, Lacy BE. Dig Dis Sci 2017; 62: 2231–2240. doi: 10.1007/s10620-017-4679-7

01-27-2017 | Gastroparesis | Book chapter | Article

Diabetic gastroparesis

Tansel A, Husain N. In: Managing Gastrointestinal Complications of Diabetes. Edited by Sellin J. Adis, Cham, 2017. doi: 10.1007/978-3-319-48662-8_3

01-21-2017 | Gastrointestinal disorders | Article

The burdens, concerns, and quality of life of patients with gastroparesis

Yu D et al. Dig Dis Sci 2017; 62: 879–893. doi: 10.1007/s10620-017-4456-7

image credits